Related Experiment Video
Updated: Sep 26, 2026
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
[Induction of apoptosis by preoperative passive immunotherapy in resectable stomach carcinoma]
W Timmermann1, B Illert, H P Vollmers
1Chirurgische Universitätsklinik, Universität Würzburg, Josef-Schneider-Strasse 2, 97080 Würzburg.
Abstract:
The antibody SC-1 is a human IGM molecule, which binds to a tumor specific receptor. This SC-1 receptor is detectable on biopsies, it is present in about 50% of gastric cancers. After binding of the antibody to the receptor the tumor cells go into apoptosis. 50 patients expressing the SC-1 receptor on their tumors have been treated with SC-1 prior to gastrectomy. In 80% of cases apoptosis induction could be demonstrated in the tumors. The only side effect of the SC-1 therapy was a reversible episode of fever during antibody infusion in 8% of our patients.